INTRODUCTION Psoriasis is a chronic, immune-mediated inflammatory skin disorder that affects 2-3% of Americans.1, 2 Plaque psoriasis is the most common form, accounting for 90% of psoriatic cases.2, 3 Classically,…

INTRODUCTIONPsoriasis is a chronic immune-mediated disorder commonly manifesting as silver-scaly plaques on an erythematous base, that has been reported at rates of up to 6.5% in certain areas of the…

INTRODUCTION Psoriasis is a common chronic inflammatory skin disease, with a strong genetic basis characterized by complex alterations in epidermal growth and differentiation. The disease is enormously variable in duration…

INTRODUCTIONPsoriasis patients may experience a significantly impaired health-related quality of life (HRQoL),1,2 causing negative psychosocial effects such as feelings of stress, stigmatization, embarrassment, and self-consciousness.3,4 Active disease is also associated…

INTRODUCTION A two-compound ointment containing 50 μg/g calcipotriene plus 0.5 mg/g betamethasone (as dipropionate) has good efficacy and is a safe treatment for psoriasis vulgaris of the body.1 However, in…

INTRODUCTIONPsoriasis treatment with traditional systemic or biologic therapies may be compromised by safety and tolerability concerns, administration (injection versus oral), and lack/loss of response.1-5 Efficacious, safe, well-tolerated, and easy-to-use treatment…

INTRODUCTION Psoriasis is an inflammatory skin condition affecting approximately 2-3% of the United States and world populations.1, 2 It is a systemic inflammatory state that is associated with an increased…

INTRODUCTIONPsoriasis is a chronic, immunologic disease that affects up to 4% of the population.1 The majority of individuals diagnosed with psoriasis have mild or localized disease, affecting less than 3%…

INTRODUCTION Tinea pedis (“athlete’s foot”) is the most common chronic, inflammatory fungal infection.1 It is estimated to be present at any one time in 15-20 percent of the US population,…

INTRODUCTIONRosacea is commonly described as a chronic inflammatory cutaneous disorder, primarily affecting the central facial zone (cheeks, chin, nose and central forehead). It is characterized by various cutaneous symptoms such…

INTRODUCTION Tumor necrosis factor alpha (TNF-alpha) is an inflammatory cytokine involved in the pathogenesis of many inflammatory conditions, including psoriasis. Thus, TNF-alpha inhibitors have been used in the treatment of…

BACKGROUNDNoninvasive procedures with little to no downtime that offer significant improvement to the aging appearance of the skin and underlying musculature are often preferred to surgical procedures. Although no procedure…